Shivansh Finserve is a financial services company that primarily earns income through interest on loans and investments, while also engaging in the trading of goods.
The company lacks any identifiable competitive advantage, as evidenced by extremely low average ROCE of 2.2% and ROE of 0.8%. Its business model relies on interest income from unsecured loans and small-scale trading, which are highly commoditized activities with no pricing power.
Management has primarily deployed capital into unsecured loans to third parties and related entities, alongside a recent strategic shift to acquire minority stakes in logistics companies via share swaps. The historical returns on these allocations have been poor, failing to generate meaningful shareholder value.
The company collapsed after its aggressive strategy of issuing shares for minority stakes in private logistics firms resulted in massive dilution without any corresponding cash flow. The lack of internal controls and the absence of an internal auditor allowed the unsecured loan book—heavily weighted toward related parties—to sour without recourse. As interest income dried up and the statutory auditors resigned yet again, the market realized the entity was less a financial services firm and more a vehicle for capital recycling among insiders, leading to a total loss of liquidity and a terminal decline in share value.
RichFakir rates Shivansh Finserve Ltd's business quality as poor — 17/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shivansh Finserve Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shivansh Finserve Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shivansh Finserve Ltd's fair value is about ₹1 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →